Post-transplant plasmapheresis is not necessary for ABO-incompatible living donor kidney transplantation

被引：0
|
作者：
Aikawa, A
Arai, K
Tajima, E
Kawamura, T
Muramatsu, M
Itabashi, Y
Hirayama, N
Ohara, T
Hasegawa, A
Sakai, K
Mizuiri, S
机构：
[1] Toho Univ, Sch Med, Tokyo, Japan
[2] Ota Gen Hosp, Gunma, Japan
[3] Odawara Junkanki Hosp, Odawara, Kanagawa, Japan
[4] Nishi Yokohama Int Hosp, Yokohama, Kanagawa, Japan
来源：
XENOTRANSPLANTATION | 2005年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：361 / 361
页数：1
相关论文
共 50 条
  • [31] EXCELLENT SHORT TERM OUTCOMES OF ABO-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION
    Jeong, Jong Cheol
    Koo, Tai Yeon
    Jeon, Hee Jung
    Han, Miyeun
    Oh, Kook-Hwan
    Ahn, Curie
    Yang, Jaeseok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 553 - 553
  • [32] ABO-INCOMPATIBLE (ABOI) LIVING DONOR WITH KIDNEY TRANSPLANTATION: STUDY OF 38 PATIENTS
    Fernandez Rivera, Constantino
    Calvo Rodriguez, Maria
    Otero Alonso, Pablo
    Lopez Muniz, Andres
    Ferreiro Hermida, Tamara
    Alonso Hernandez, Angel
    TRANSPLANT INTERNATIONAL, 2017, 30 : 340 - 341
  • [33] ABO-Incompatible Living-Related-Donor Kidney Transplantation in Alagille Syndrome
    Goto, Miwa
    Hataya, Hiroshi
    Ishikura, Kenji
    Hamasaki, Yuko
    Sakai, Tomoyuki
    Kosaki, Kenjiro
    Honda, Masataka
    PEDIATRIC NEPHROLOGY, 2011, 26 (05) : 832 - 832
  • [34] Cancer Risk After ABO-Incompatible Living-Donor Kidney Transplantation
    Hall, Erin C.
    Engels, Eric A.
    Montgomery, Robert A.
    Segev, Dorry L.
    TRANSPLANTATION, 2013, 96 (05) : 476 - 479
  • [35] Evaluation of Rituximab Dosage for ABO-Incompatible Living-donor Kidney Transplantation
    Nakao, T.
    Ushigome, H.
    Kawai, K.
    Nakamura, T.
    Harada, S.
    Koshino, K.
    Suzuki, T.
    Ito, T.
    Nobori, S.
    Yoshimura, N.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) : 644 - 648
  • [36] A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation
    Eung Chang Lee
    Seong Hoon Kim
    Jae Ryong Shim
    Sang-Jae Park
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (02) : 119 - 125
  • [37] A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation
    Lee, E.
    Kim, S.
    Lee, S.
    Park, S. -J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 392 - 392
  • [38] A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-incompatible Living Donor Liver Transplantation
    Lee, E. C.
    Kim, S. H.
    Lee, S. D.
    Park, S. -J
    TRANSPLANTATION, 2017, 101 (05) : 16 - 16
  • [39] Kidney Transplantation of Living Unrelated and ABO-Incompatible Donor-Recipient Combinations
    Ishikawa, N.
    Yagisawa, T.
    Kimura, T.
    Sakuma, Y.
    Fujiwara, T.
    Nukui, A.
    Yashi, M.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (03) : 1242 - 1244
  • [40] A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation
    Lee, Eung Chang
    Kim, Seong Hoon
    Shim, Jae Ryong
    Park, Sang-Jae
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (02) : 119 - 125
12345